IMR-5/75 neuroblastoma cells, either untreated or pretreated with the KDM1A inhibitor, were incubated with an antibody that blocks FAS binding to its ligand without inducing FAS-directed cell death prior to exposure to CAR T cells. The gene discussed is KDM1A; the disease is neuroblastoma.